Drug Database
Back to search

Netherlands· NL-5dc8a46436eb

Alkindi 1 mg granulaat in capsules om te openen

A hydrocortisone product containing hydrocortison + indigokarmijn (e 132), registered in Netherlands by Immedica Pharma AB. The same ATC class is registered in 14 of our 19 countries.

ATC H02AB09

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAlkindi 1 mg granulaat in capsules om…ATCH02AB09REGISTER NO.NL-5dc8a46436ebPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about hydrocortison + indigokarmijn (e 132)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Hydrocortisone is registered in 14 of 19 countries.

Countries holding a registration under ATC H02AB09 (hydrocortisone), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search hydrocortisone products by name

Hydrocortisone · ATC H02AB09

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of hydrocortisone costs, country by country.

Normalised to the WHO defined daily dose (30 mg), the median price runs from $1.17 in Czechia to $31.20 in Switzerland — a ×27 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Hydrocortisone · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$31.20
  • CZ Czechia$1.17
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
HYDROCORTISON + INDIGOKARMIJN (E 132)
Manufacturer
Immedica Pharma AB
Country
Netherlands (NL)
ATC code
H02AB09
ATC class
Hydrocortisone
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/17/1260

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

845 interactions on record for hydrocortisone.

Graded by severity as the source publishes them — 63 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check hydrocortisone against other medicinesHow interaction checks work

Hydrocortisone · interactions on record

845 records

  • 63 severe
  • 407 moderate
  • 40 minor
  • 315 info

Most severe, free to view

  • DesirudinB01AE01severe
  • AmiodaroneC01BD01severe
  • DofetilideC01BD04severe
  • DronedaroneC01BD07severe

20 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under H02AB09

Hydrocortisone, as other registers publish it.

All hydrocortisone products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ac899d9f-7404-4eb1-a629-88d413552048
GET /v1/drugs/ac899d9f-7404-4eb1-a629-88d413552048?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Granulaat",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/alkindi-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Hydrocortisone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp120343",
  "excipients": [
    "AMMONIA (E 527)",
    "BLAUWE INKT",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "ETHYLCELLULOSE (E 462)",
    "HYPROMELLOSE (E 464)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK (E 904)"
  ],
  "substances": [
    "HYDROCORTISON",
    "INDIGOKARMIJN (E 132)"
  ],
  "leaflet_url": null,
  "authorised_at": "2018/02/09",
  "procedure_number": "EMEA/H/C/004416",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/17/1260",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about hydrocortisone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console